High income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
High income
Records
63
Source
High income | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 46.2959103
1981 52.33587016
1982 54.84111176
1983 63.39975699
1984 68.84837519
1985 72.81241734
1986 75.10174928
1987 74.98850087
1988 80.17407984
1989 82.70242674
1990 84.2574309
1991 83.98962603
1992 82.63874086
1993 83.79066332
1994 87.29309477
1995 88.66296857
1996 89.99189312
1997 89.89177694
1998 89.90713244
1999 90.79788217
2000 91.32110386
2001 91.76962371
2002 92.2669288
2003 92.94120461
2004 93.16755073
2005 92.84396137
2006 93.07651994
2007 93.09251909
2008 93.18873204
2009 92.45631093
2010 93.35826897
2011 93.44709925
2012 93.61177078
2013 93.80524695
2014 94.0554938
2015 93.70092522
2016 93.61333145
2017 93.48960422
2018 93.97784377
2019 93.24412714
2020 93.0383227
2021 93.08759068
2022 93.17210176

High income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
High income
Records
63
Source